Loading…

Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis : Effect of enalapril

Chronic hypoxia induces pulmonary hypertension and right ventricular hypertrophy. These changes are completely reversible, except for persistent myocardial fibrosis. The aim of the present study was to determine whether treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril can r...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy 1997-04, Vol.11 (2), p.177-185
Main Authors: PELOUCH, V, KOLAR, F, OST'ADAL, B, MILEROVA, M, CIHAK, R, WIDIMSKY, J
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c281t-b0a995736c49d94955df399052cda2e0eae3dbb7bf806144f9f0300601b396343
cites
container_end_page 185
container_issue 2
container_start_page 177
container_title Cardiovascular drugs and therapy
container_volume 11
creator PELOUCH, V
KOLAR, F
OST'ADAL, B
MILEROVA, M
CIHAK, R
WIDIMSKY, J
description Chronic hypoxia induces pulmonary hypertension and right ventricular hypertrophy. These changes are completely reversible, except for persistent myocardial fibrosis. The aim of the present study was to determine whether treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril can reduce the ventricular collagen content in animals recovering from chronic hypoxia. Adult male Wistar rats were exposed to intermittent high-altitude hypoxia simulated in a barochamber (7000 m, 8 hr/day, 5 days a week, 24 exposures), then transferred to normoxia and divided into two groups: (a) treated with enalapril (0.1 g/kg/day for 60 days) and (b) without treatment. The corresponding control groups were kept under normoxic conditions. Enalapril significantly decreased the heart rate, systemic arterial pressure, and absolute left and right ventricular weights in both hypoxic and control rats; on the other hand, the pulmonary blood pressure was unchanged. The content and concentration of collagen was reduced in both ventricles of enalapril-treated hypoxic and control animals by 10-26% compared with the corresponding untreated groups. These data suggest that the partial regression of cardiac fibrosis due to enalapril may be independent of the pressure load.
doi_str_mv 10.1023/A:1007788915732
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78997982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78997982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-b0a995736c49d94955df399052cda2e0eae3dbb7bf806144f9f0300601b396343</originalsourceid><addsrcrecordid>eNo9kD1PwzAQhi0EKqUwMyF5QEwNnO00ybFVVfmQKiEhmCvHsVuj1A52gujEXycVEdMNz3Mf7xFyyeCWARd383sGkOdFgWyWC35Exoea5Dxlx2QMyCERHLJTchbjB_QqYjEiI2QpZJiOyc-r3gQdo_WOekPVNnhnFd3uG_9tZWJd1Sld0aard97JsD8QHVrtDh1TGuxm29Iv7dpgVVfLMPDgm-1-SqWrqLFl8NFGek-XxmjVHvZoJ2vZBFufkxMj66gvhjoh7w_Lt8VTsnp5fF7MV4niBWuTEiRiHyxTKVaY4mxWGYEIM64qyTVoqUVVlnlpCshYmho0IAAyYKXATKRiQm7-5jbBf3Y6tuudjUrXtXTad3GdF4g5FrwXrwaxK3e6WvdH7vrc6-FjPb8euIxK1iZIp2z813iWASIXv_jrfEk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78997982</pqid></control><display><type>article</type><title>Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis : Effect of enalapril</title><source>Springer Nature</source><creator>PELOUCH, V ; KOLAR, F ; OST'ADAL, B ; MILEROVA, M ; CIHAK, R ; WIDIMSKY, J</creator><creatorcontrib>PELOUCH, V ; KOLAR, F ; OST'ADAL, B ; MILEROVA, M ; CIHAK, R ; WIDIMSKY, J</creatorcontrib><description>Chronic hypoxia induces pulmonary hypertension and right ventricular hypertrophy. These changes are completely reversible, except for persistent myocardial fibrosis. The aim of the present study was to determine whether treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril can reduce the ventricular collagen content in animals recovering from chronic hypoxia. Adult male Wistar rats were exposed to intermittent high-altitude hypoxia simulated in a barochamber (7000 m, 8 hr/day, 5 days a week, 24 exposures), then transferred to normoxia and divided into two groups: (a) treated with enalapril (0.1 g/kg/day for 60 days) and (b) without treatment. The corresponding control groups were kept under normoxic conditions. Enalapril significantly decreased the heart rate, systemic arterial pressure, and absolute left and right ventricular weights in both hypoxic and control rats; on the other hand, the pulmonary blood pressure was unchanged. The content and concentration of collagen was reduced in both ventricles of enalapril-treated hypoxic and control animals by 10-26% compared with the corresponding untreated groups. These data suggest that the partial regression of cardiac fibrosis due to enalapril may be independent of the pressure load.</description><identifier>ISSN: 0920-3206</identifier><identifier>EISSN: 1573-7241</identifier><identifier>DOI: 10.1023/A:1007788915732</identifier><identifier>PMID: 9140694</identifier><identifier>CODEN: CDTHET</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Altitude Sickness - physiopathology ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Animals ; Antihypertensive agents ; Biological and medical sciences ; Body Weight - drug effects ; Body Weight - physiology ; Cardiovascular system ; Chronic Disease ; Collagen - metabolism ; Enalapril - therapeutic use ; Hemodynamics - drug effects ; Hydroxyproline - metabolism ; Hypertension, Pulmonary - drug therapy ; Hypertension, Pulmonary - etiology ; Hypertension, Pulmonary - physiopathology ; Hypertrophy, Right Ventricular - drug therapy ; Hypertrophy, Right Ventricular - physiopathology ; Hypoxia - complications ; Hypoxia - physiopathology ; Male ; Medical sciences ; Myocardium - metabolism ; Organ Size - drug effects ; Organ Size - physiology ; Pharmacology. Drug treatments ; Pulmonary Fibrosis - drug therapy ; Pulmonary Fibrosis - etiology ; Rats ; Rats, Wistar ; Space life sciences</subject><ispartof>Cardiovascular drugs and therapy, 1997-04, Vol.11 (2), p.177-185</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c281t-b0a995736c49d94955df399052cda2e0eae3dbb7bf806144f9f0300601b396343</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2660992$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9140694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PELOUCH, V</creatorcontrib><creatorcontrib>KOLAR, F</creatorcontrib><creatorcontrib>OST'ADAL, B</creatorcontrib><creatorcontrib>MILEROVA, M</creatorcontrib><creatorcontrib>CIHAK, R</creatorcontrib><creatorcontrib>WIDIMSKY, J</creatorcontrib><title>Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis : Effect of enalapril</title><title>Cardiovascular drugs and therapy</title><addtitle>Cardiovasc Drugs Ther</addtitle><description>Chronic hypoxia induces pulmonary hypertension and right ventricular hypertrophy. These changes are completely reversible, except for persistent myocardial fibrosis. The aim of the present study was to determine whether treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril can reduce the ventricular collagen content in animals recovering from chronic hypoxia. Adult male Wistar rats were exposed to intermittent high-altitude hypoxia simulated in a barochamber (7000 m, 8 hr/day, 5 days a week, 24 exposures), then transferred to normoxia and divided into two groups: (a) treated with enalapril (0.1 g/kg/day for 60 days) and (b) without treatment. The corresponding control groups were kept under normoxic conditions. Enalapril significantly decreased the heart rate, systemic arterial pressure, and absolute left and right ventricular weights in both hypoxic and control rats; on the other hand, the pulmonary blood pressure was unchanged. The content and concentration of collagen was reduced in both ventricles of enalapril-treated hypoxic and control animals by 10-26% compared with the corresponding untreated groups. These data suggest that the partial regression of cardiac fibrosis due to enalapril may be independent of the pressure load.</description><subject>Altitude Sickness - physiopathology</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Animals</subject><subject>Antihypertensive agents</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Body Weight - physiology</subject><subject>Cardiovascular system</subject><subject>Chronic Disease</subject><subject>Collagen - metabolism</subject><subject>Enalapril - therapeutic use</subject><subject>Hemodynamics - drug effects</subject><subject>Hydroxyproline - metabolism</subject><subject>Hypertension, Pulmonary - drug therapy</subject><subject>Hypertension, Pulmonary - etiology</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Hypertrophy, Right Ventricular - drug therapy</subject><subject>Hypertrophy, Right Ventricular - physiopathology</subject><subject>Hypoxia - complications</subject><subject>Hypoxia - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardium - metabolism</subject><subject>Organ Size - drug effects</subject><subject>Organ Size - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Fibrosis - drug therapy</subject><subject>Pulmonary Fibrosis - etiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Space life sciences</subject><issn>0920-3206</issn><issn>1573-7241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9kD1PwzAQhi0EKqUwMyF5QEwNnO00ybFVVfmQKiEhmCvHsVuj1A52gujEXycVEdMNz3Mf7xFyyeCWARd383sGkOdFgWyWC35Exoea5Dxlx2QMyCERHLJTchbjB_QqYjEiI2QpZJiOyc-r3gQdo_WOekPVNnhnFd3uG_9tZWJd1Sld0aard97JsD8QHVrtDh1TGuxm29Iv7dpgVVfLMPDgm-1-SqWrqLFl8NFGek-XxmjVHvZoJ2vZBFufkxMj66gvhjoh7w_Lt8VTsnp5fF7MV4niBWuTEiRiHyxTKVaY4mxWGYEIM64qyTVoqUVVlnlpCshYmho0IAAyYKXATKRiQm7-5jbBf3Y6tuudjUrXtXTad3GdF4g5FrwXrwaxK3e6WvdH7vrc6-FjPb8euIxK1iZIp2z813iWASIXv_jrfEk</recordid><startdate>19970401</startdate><enddate>19970401</enddate><creator>PELOUCH, V</creator><creator>KOLAR, F</creator><creator>OST'ADAL, B</creator><creator>MILEROVA, M</creator><creator>CIHAK, R</creator><creator>WIDIMSKY, J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19970401</creationdate><title>Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis : Effect of enalapril</title><author>PELOUCH, V ; KOLAR, F ; OST'ADAL, B ; MILEROVA, M ; CIHAK, R ; WIDIMSKY, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-b0a995736c49d94955df399052cda2e0eae3dbb7bf806144f9f0300601b396343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Altitude Sickness - physiopathology</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Animals</topic><topic>Antihypertensive agents</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Body Weight - physiology</topic><topic>Cardiovascular system</topic><topic>Chronic Disease</topic><topic>Collagen - metabolism</topic><topic>Enalapril - therapeutic use</topic><topic>Hemodynamics - drug effects</topic><topic>Hydroxyproline - metabolism</topic><topic>Hypertension, Pulmonary - drug therapy</topic><topic>Hypertension, Pulmonary - etiology</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Hypertrophy, Right Ventricular - drug therapy</topic><topic>Hypertrophy, Right Ventricular - physiopathology</topic><topic>Hypoxia - complications</topic><topic>Hypoxia - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardium - metabolism</topic><topic>Organ Size - drug effects</topic><topic>Organ Size - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Fibrosis - drug therapy</topic><topic>Pulmonary Fibrosis - etiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Space life sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PELOUCH, V</creatorcontrib><creatorcontrib>KOLAR, F</creatorcontrib><creatorcontrib>OST'ADAL, B</creatorcontrib><creatorcontrib>MILEROVA, M</creatorcontrib><creatorcontrib>CIHAK, R</creatorcontrib><creatorcontrib>WIDIMSKY, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular drugs and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PELOUCH, V</au><au>KOLAR, F</au><au>OST'ADAL, B</au><au>MILEROVA, M</au><au>CIHAK, R</au><au>WIDIMSKY, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis : Effect of enalapril</atitle><jtitle>Cardiovascular drugs and therapy</jtitle><addtitle>Cardiovasc Drugs Ther</addtitle><date>1997-04-01</date><risdate>1997</risdate><volume>11</volume><issue>2</issue><spage>177</spage><epage>185</epage><pages>177-185</pages><issn>0920-3206</issn><eissn>1573-7241</eissn><coden>CDTHET</coden><abstract>Chronic hypoxia induces pulmonary hypertension and right ventricular hypertrophy. These changes are completely reversible, except for persistent myocardial fibrosis. The aim of the present study was to determine whether treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril can reduce the ventricular collagen content in animals recovering from chronic hypoxia. Adult male Wistar rats were exposed to intermittent high-altitude hypoxia simulated in a barochamber (7000 m, 8 hr/day, 5 days a week, 24 exposures), then transferred to normoxia and divided into two groups: (a) treated with enalapril (0.1 g/kg/day for 60 days) and (b) without treatment. The corresponding control groups were kept under normoxic conditions. Enalapril significantly decreased the heart rate, systemic arterial pressure, and absolute left and right ventricular weights in both hypoxic and control rats; on the other hand, the pulmonary blood pressure was unchanged. The content and concentration of collagen was reduced in both ventricles of enalapril-treated hypoxic and control animals by 10-26% compared with the corresponding untreated groups. These data suggest that the partial regression of cardiac fibrosis due to enalapril may be independent of the pressure load.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>9140694</pmid><doi>10.1023/A:1007788915732</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-3206
ispartof Cardiovascular drugs and therapy, 1997-04, Vol.11 (2), p.177-185
issn 0920-3206
1573-7241
language eng
recordid cdi_proquest_miscellaneous_78997982
source Springer Nature
subjects Altitude Sickness - physiopathology
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Animals
Antihypertensive agents
Biological and medical sciences
Body Weight - drug effects
Body Weight - physiology
Cardiovascular system
Chronic Disease
Collagen - metabolism
Enalapril - therapeutic use
Hemodynamics - drug effects
Hydroxyproline - metabolism
Hypertension, Pulmonary - drug therapy
Hypertension, Pulmonary - etiology
Hypertension, Pulmonary - physiopathology
Hypertrophy, Right Ventricular - drug therapy
Hypertrophy, Right Ventricular - physiopathology
Hypoxia - complications
Hypoxia - physiopathology
Male
Medical sciences
Myocardium - metabolism
Organ Size - drug effects
Organ Size - physiology
Pharmacology. Drug treatments
Pulmonary Fibrosis - drug therapy
Pulmonary Fibrosis - etiology
Rats
Rats, Wistar
Space life sciences
title Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis : Effect of enalapril
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A29%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regression%20of%20chronic%20hypoxia-induced%20pulmonary%20hypertension,%20right%20ventricular%20hypertrophy,%20and%20fibrosis%20:%20Effect%20of%20enalapril&rft.jtitle=Cardiovascular%20drugs%20and%20therapy&rft.au=PELOUCH,%20V&rft.date=1997-04-01&rft.volume=11&rft.issue=2&rft.spage=177&rft.epage=185&rft.pages=177-185&rft.issn=0920-3206&rft.eissn=1573-7241&rft.coden=CDTHET&rft_id=info:doi/10.1023/A:1007788915732&rft_dat=%3Cproquest_pubme%3E78997982%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c281t-b0a995736c49d94955df399052cda2e0eae3dbb7bf806144f9f0300601b396343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78997982&rft_id=info:pmid/9140694&rfr_iscdi=true